146 related articles for article (PubMed ID: 1646295)
21. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
22. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
Ikeda H; Koshikawa N; Cools AR
Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
[TBL] [Abstract][Full Text] [Related]
23. Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors.
Morelli M; Fenu S; Di Chiara G
Brain Res; 1989 May; 487(1):120-30. PubMed ID: 2546645
[TBL] [Abstract][Full Text] [Related]
24. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
25. Combination of a delta opioid receptor agonist but not a mu opioid receptor agonist with the D1-selective dopamine receptor agonist SKF 38393 markedly potentiates different behaviors in mice.
Toyoshi T; Ukai M; Kameyama T
Eur J Pharmacol; 1992 Mar; 213(1):25-30. PubMed ID: 1354161
[TBL] [Abstract][Full Text] [Related]
26. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
[TBL] [Abstract][Full Text] [Related]
27. Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens.
Ragnauth A; Znamensky V; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 877(1):65-72. PubMed ID: 10980244
[TBL] [Abstract][Full Text] [Related]
28. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
Salmi P; Kela J; Arvidsson U; Wahlestedt C
Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
[TBL] [Abstract][Full Text] [Related]
29. Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors.
Churchill L; Roques BP; Kalivas PW
Psychopharmacology (Berl); 1995 Aug; 120(3):347-55. PubMed ID: 8524983
[TBL] [Abstract][Full Text] [Related]
30. Stimulation of accumbal GABA
Aono Y; Kiguchi Y; Watanabe Y; Waddington JL; Saigusa T
Eur J Pharmacol; 2017 Nov; 815():18-25. PubMed ID: 28923348
[TBL] [Abstract][Full Text] [Related]
31. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
32. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
Ragnauth A; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
Wild KD; Carlisi VJ; Mosberg HI; Bowen WD; Portoghese PS; Sultana M; Takemori AE; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Feb; 264(2):831-8. PubMed ID: 8382281
[TBL] [Abstract][Full Text] [Related]
34. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
35. Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice.
Zhao GM; Bhargava HN
Peptides; 1996; 17(4):619-23. PubMed ID: 8804071
[TBL] [Abstract][Full Text] [Related]
36. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
Kalra A; Urban MO; Sluka KA
J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
[TBL] [Abstract][Full Text] [Related]
37. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
Churchill L; Kalivas PW
Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
[TBL] [Abstract][Full Text] [Related]
38. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.
Daugé V; Rossignol P; Roques BP
Psychopharmacology (Berl); 1988; 96(3):343-52. PubMed ID: 2851851
[TBL] [Abstract][Full Text] [Related]
40. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
